I. Missense mutation T485S alters NBCe1-A electrogenicity causing proximal renal tubular acidosis.
, our result indicated that NBCe1-A mediates electrogenic Na ϩ -CO 3 2Ϫ cotransport when functioning with a 1:2 charge transport stoichiometry. In contrast, electroneutral NBCe1-T485S is unable to transport NO 3 Ϫ , compatible with the hypothesis that it mediates Na ϩ -HCO 3 Ϫ cotransport. In patients, NBCe1-A-T485S is predicted to transport Na ϩ -HCO 3 Ϫ in the reverse direction from blood into proximal tubule cells thereby impairing transepithelial HCO 3 Ϫ absorption, possibly representing a new pathogenic mechanism for generating human pRTA.
pRTA; NBCe1-A; T485S; electrogenicity; CO 3 2Ϫ PROXIMAL RENAL TUBULAR ACIDOSIS (pRTA) is caused by various acquired and genetic diseases that impair HCO 3 Ϫ absorption in the proximal tubule (9) . The kidney variant of the electrogenic Na ϩ -HCO 3 Ϫ cotransporter, NBCe1-A, is located on the basolateral membrane of the proximal tubule cells where it is responsible for absorbing base from the lumen to blood (3, 31) . Missense and nonsense mutations in NBCe1 cause congenital autosomal recessive pRTA associated with a severe metabolic acidosis, growth retardation, brain, eye and teeth abnormalities (7, 8, 15-17, 23, 37, 38) . Mutations in NBCe1-A have been reported to cause protein truncation, endoplasmic reticulum (ER) retention, abnormal targeting, or decreased base transport function (7, 8, 15-17, 21, 23, 37-39) .
NBCe1-A mediates proximal tubular transepithelial HCO 3 Ϫ absorption by transporting Na ϩ and base electrogenically from cytoplasm to blood opposing the substrate ion concentration gradients (3, 31) . The transporter exists as a homodimer with each monomer functioning independently (18) . Each NBCe1-A monomer consists of 1,035 amino acids with both of the NH 2 and COOH termini located in the cytosol. The NH 2 -terminal cytoplasmic region is predicted to be compactly folded and interacts with the COOH-terminal lipid embedded transmembrane region (45) . The COOH-terminal cytoplasmic tail is critically involved in NBCe1-A plasma membrane processing (22, 26, 38) . The transmembrane region of NBCe1-A contains 14 transmembrane segments (TM), and the last five TMs may participate in forming a scaffold to accommodate NBCe1-A substrate ion interaction sites (45, 46) . Three amino acids in NBCe1-A-TM1 (Ala428, Ala435, and Thr442) (44) and one amino acid in TM8 (Leu750) (25) have been determined to line the ion permeation pathway and are potentially involved in ion translocation. Asp555 in TM5 has been implicated in playing an important role in anion selectivity (42) , and extracellular loop 4 was reported to play a role in the electrogenicity of NBCe1-A although the mechanism is currently unclear (5) .
Eight missense mutations (R298S, S427L, T485S, G486R, R510H, L522P, A799V, and R881C) in NBCe1-A have thus far been reported to cause pRTA (7, 8, 15, 16, 37) . Based on our most recent NBCe1-A topological model (46) , all the residues mutated in pRTA (pRTA residues) are located in the transmembrane region (TM1, 3, 4, 10, and 12, respectively) of the transporter except R298S, which resides in the NH 2 -terminal cytoplasmic domain. The transmembrane region-localized pRTA residues are not exposed to the intra-or extracellular surface of NBCe1-A (46) , indicating that they may reside in a critical region involved in either protein folding, helices packing, or ion translocation. Specifically, R298S was predicted to affect ion entry into the NBCe1-A ion translocation pathway (4) . S427L was reported to change the polarity of membrane targeting (21) and alter the TM1 orientation affecting the configuration of the NBCe1-A ion permeation pathway (47) . The missense mutations R510H, L522P, and R881C were found to trigger mutant NBCe1-A intracellular retention (37) (38) (39) . A799V was shown to affect both ion transport and mutant protein plasma membrane expression (29) .
Unlike the aforementioned missense mutations, NBCe1-A-T485S processes to the plasma membrane normally and retains ϳ50% of wild-type NBCe1-A (wt-NBCe1-A) base transport function when expressed in ECV 304 or HEK 293 cells (15, 38, 46) . Given the structural and chemical similarities between threonine and serine, it would not be predicted that this substitution impairs NBCe1-A base transport causing pRTA. In the present study, we investigated the base transport and electrogenic properties of NBCe1-A-T485S in mammalian HEK 293 cells to address the molecular pathogenic mechanism of the T485S mutation in causing pRTA. Our results demonstrate that Ser substitution of Thr485 transforms NBCe1-A from an electrogenic transporter with charge transport stoichiometry of 1:2 to an electroneutral transporter. These findings represent the first reported single amino acid substitution that alters the electrogenicity of a membrane transporter causing human disease.
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MATERIALS AND METHODS
Materials
Site-directed mutagenesis kits were from Stratagene; N-ethylmaleimide ([ 14 C]NEM) was from PerkinElmer; BCECF-AM, DMEM, and all cell culture reagents were from Invitrogen; methanethiosulfonate (MTS) reagents [2-(trimethylammonium)ethyl MTS (MTSET) and 2-aminoethyl MTS (MTSEA)] were from Toronto Research; Sulfo-NHS-SS-biotin and streptavidin-agarose resins were from Pierce; protein A-Sepharose and goat anti-rabbit IgG-conjugated horseradish peroxidase were from GE Healthcare; Igepal and nigericin were from Sigma; polyvinylidene difluoride (PVDF) membranes were from Millipore.
Site-Directed Mutagenesis
Both wild-type and a modified human NBCe1-A cDNA with five endogenous cysteines substituted with serines (NBCe1-A-5C Ϫ ) were used as the templates for site-directed mutagenesis. Point mutations were generated using the QuickChange II site-directed mutagenesis kit (Stratagene). For enhanced green fluorescent protein (EGFP) expression constructs, human NBCe1-A cDNA was subcloned into a pIRES2-EGFP vector (Clontech) that expresses NBCe1-A (or other NBCe1-A mutant constructs) and EGFP separately.
NBCe1-A Base Flux
HEK 293 cells grown on coated coverslips were transfected using Lipofectamine 2000 with wt-NBCe1-A, NBCe1-A mutant constructs, or vector alone (mock-transfected). Twenty-four hours after transfection, the cells were loaded in a custom designed chamber with the fluorescent pH probe BCECF-AM, and intracellular pH (pH i) was measured using a microscope-fluorometer. The cells were initially equilibrated in a HEPES-buffered Na ϩ -free solution (in mM: 140 TMA-Cl, 2.5 K2HPO4, 1 CaCl2, 1 MgCl2, 5 glucose, 5 HEPES, pH 7.4) for ϳ25 min, and then pHi was acutely decreased to ϳ6.6 -6.7 in all experiments by exposing the cells to a HCO 3 Ϫ -buffered Na ϩ -free solution (in mM: 115 TMA-Cl, 2.5 K2HPO4, 1 CaCl2, 1 MgCl2, 5 glucose, 25 TMA-HCO3, pH 7.4). When a baseline was achieved, the cells were bathed in a Na ϩ -containing HCO 3 Ϫ -buffered solution (in mM: 115 NaCl, 2.5 K2HPO4, 1 CaCl2, 1 MgCl2, 5 glucose, 25 NaHCO3, pH 7.4). All HCO 3 Ϫ -buffered solutions were adjusted to pH 7.4 by bubbling with 5% CO2 and 95% O2. dpHi/dt (the rate of pHi recovery) was calculated in the initial 15 s after exposure to Na ϩ at pHi ϳ 6.6 -6.7. For experiments with MTSET preincubation, the cells were exposed to MTSET (4 mM; 5 min) in the presence or absence of ion substrates (Na ϩ or HCO 3 Ϫ -buffer) before pHi transport measurements were performed. In this regard, BCECF loading was performed after MTS incubation. In experiments using MTSEA (1 mM; 1 min), the cells were preincubated in the Na ϩ -free HEPES-buffered solution before BCECF loading and subsequent base flux measurements. Flux mediated by NBCe1-A and NBCe1-A mutant constructs was assessed as previously described (32) . In brief, in HEPES-buffered solutions, the transporter flux was calculated as ␤i (intrinsic cell buffer capacity) ϫ dpHi/dt (initial rate of change of pHi after exposure to the Na ϩ -containing solution). In HCO 3 Ϫ -containing solutions, the total cell buffer capacity (␤T) was equal to ␤i plus the HCO 3 Ϫ -buffer capacity (2.3 ϫ [HCO 3 Ϫ ]i), and flux through the transporter was calculated as dpHi/dt ϫ ␤T. To compare the flux at comparable pHi values in the different protocols, dpHi/dt in these experiments was calculated after the addition of extracellular Na ϩ at pHi ϳ6.6 -6.7. EIPA (15 M) was included in all assay solutions after MTS reagent incubation to block endogenous Na ϩ /H ϩ exchange.
Surface Expression
Sulfo-NHS-SS-biotin cell surface labeling was performed following the manufacturer's instructions (Pierce).
Immunocytochemistry
Twenty-four hours after transfection, the cells were rinsed with PBS and labeled with a rabbit anti-human NBCe1-A antibody (Ab-162, 1:100 dilution in PBS) that recognizes an epitope in NBCe1-A extracellular loop 3 (44) . After 15 min of incubation at room temperature, the cells were rinsed again with PBS and further incubated with goat anti-rabbit IgG conjugated with Cy3 (1:500 dilution in PBS; Jackson ImmunoResearch) for 30 min at room temperature. The cells were then washed with PBS and mounted in Crystal/Mount (Biomeda, Foster City, CA). Fluorescence images were acquired with a PXL camera (model CH1; Photometrics) coupled to a Nikon Microphoton-FXA epifluorescence microscope.
Electrogenicity of NBCe1-A and NBCe1-A Mutant Constructs
The electrogenicity of NBCe1 and NBCe1-A constructs was assessed using whole cell patch clamping. HEK 293 cells were transfected with NBCe1-A or NBCe1-A mutant constructs (using Lipofectamine 2000) cloned into the pIRES2-EGFP vector expressing both EGFP and NBCe1-A under separate promoters. Forty-eight hours after transfection, cells were collected and replated at 1:10 dilution. After 12 h, cells with moderate EGFP intensity were selected for electrophysiological recording. Cells were continuously perfused (ϳ2 ml/min) at room temperature (22-24°C). Whole cell patch clamping was performed with a patch amplifier (MultiClamp 700B; Molecular Devices, Foster City, CA). Patch pipettes were prepared from borosilicate glass capillaries, and the tip diameter was 1-1.5 m (resistance: 4 -6.5 M⍀). A micro-agar salt bridge containing 2 M KCl was built in the electrode holder to ensure stable electrode potential during recording (35) . The steady-state currents were measured at a holding potential of Ϫ60 mV, and a series of 400-ms voltage pulses with an increment of 10 mV was applied. Recorded currents were low pass filtered at 400 Hz and sampled at 2 kHz using pClamp software (Clampex 10, Molecular Devices). Junction potentials generated by different composition of patch and bath solutions (calculated with Clampex 10) were corrected for all applied potentials. In the electrogenicity studies, the patch solution contained (in mM) 125 Csgluconate, 10 Na-gluconate, 1 CaCl 2, 1 ATP-Mg, 1 ATP-Na2, 10 TEA-Cl, 10 EGTA, 10 HEPES, pH 7.4, and the bath solutions contained (in mM) 110 NaCl, 1.5 CaCl2, 1 MgCl2, 10 CsCl, 15 glucose, 10 HEPES, pH 7.4, with 25 mM Na-gluconate or 25 mM NaHCO 3. In the charge transport stoichiometry measurements, current-voltage (I-V) curves were obtained in the presence and absence of DIDS (1 mM) to determine the NBCe1-A-specific current. Reversal potential (E rev) was measured at two different pipette-bath Na (19) .
Protein Expression and [ 14 C]NEM Labeling
Forty-eight hours after transfection, HEK 293 cell membranes were prepared as described (46) . [ 14 C]NEM labeling was performed as described previously (13) -free solution and monitoring the pHi changes. In separate experiments, ␣-cyano-4-hydroxycinnamate (␣-CHC; 2 mM) was included in both solutions to block the endogenous H ϩ -NO 3 Ϫ cotransport process (6) . EIPA (15 M) was used in all solutions to block endogenous residual Na
To monitor the pHi changes resulting from the stimulation of endogenous H ϩ -NO 3 Ϫ cotransport induced by NBCe1-A Na ϩ -driven NO 3 Ϫ transport, the following experiments were performed. The cells were first equilibrated (5 min) in a Na ϩ -free HEPESbuffered solution containing 15 mM NH4Cl (in mM: 125 TMA-Cl, 15 NH4Cl, 2.5 K2HPO4, 1 CaCl2, 1 MgCl2, 5 glucose, 5 HEPES, Ϫ -buffered solution induces an increase in intracellular pH (pHi) in wt-NBCe1-A (black), which is less rapid in T485S/C (red and blue) and absent in mock-transfected cells (green). C: mean results of the experiments depicted in B showing that the loss of Thr485 significantly decreases the Na ϩ -dependent base flux by ϳ50%. *P Ͻ 0.05. D: surface processing of wt-NBCe1-A, T485S, and T485C. Protein levels of each of the constructs were determined by NHS-SS-biotin surface labeling, which showed that all constructs were processed equally to the plasma membrane. GAPDH was used as an internal standard. Error bars represent means Ϯ SE (n ϭ 5). pH 7.4). pHi was then acutely decreased by bathing the cells in an NH 4 ϩ -and Na ϩ -free solution containing NO 3 Ϫ (in mM: 115 TMACl, 25 TMA-NO3, 2.5 K2HPO4, 1 CaCl2, 1 MgCl2, 5 glucose, 5 HEPES, pH 7.4). After the baseline had stabilized, the ability of NBCe1-A to mediate Na ϩ -driven NO 3 Ϫ transport was assessed by bathing the cells in a Na ϩ -containing HEPES-buffered NO 3 Ϫ -containing solution (in mM: 115 NaCl, 25 NaNO3, 2.5 K2HPO4, 1 CaCl2, 1 MgCl2, 5 glucose, 5 HEPES, pH 7.4). EIPA (15 M) was included in all solutions to block endogenous Na ϩ /H ϩ exchange activity.
Image and Data Analysis
Films from [
14 C]NEM and immunoblots were scanned with a Hewlett-Packard Scanjet 5590. Scanned images were quantified with UN-SCAN-IT gel software (version 6.1). [
14 C]NEM incorporation levels were calculated as described previously (47) .
Statistical Analysis
Statistical analysis was performed using SigmaPlot. Results are reported as means Ϯ SE. Dunnett's t-test was used to assess statistical significance with P Ͻ 0.05 considered significant.
RESULTS
Effect of T485S Mutation on NBCe1-A Ion Transport
NBCe1-A electrogenically cotransports Na . This functional impairment is not caused by the level of mutant protein expression since it expressed equally as the wtNBCe1-A on the plasma membrane (Fig. 1D) . Additional experiments showed that cysteine substitution of T485 also decreased NBCe1-A base transport by ϳ50% to 9.09 Ϯ 0.62 mM/min (n ϭ 11, P Ͻ 0.05) versus control, indicating that the loss of Thr485 per se rather than the serine substitution caused pRTA (Fig. 1, B-D) .
The electrogenicity of T485S was examined by using whole cell patch clamping. HEK 293 cells expressing NBCe1-A were identified using a pIRES2-EGFP vector that encodes both EGFP and NBCe1-A under separate promoters. This prevented any potential effect of EGFP on NBCe1-A function if they had been coupled. Figure 2A shows that NBCe1-A is well processed to the plasma membrane in cells expressing EGFP in the cytoplasm. For electrophysiological recordings, we selectively patch clamped cells with moderate EGFP intensity. Figure 2 , B-E, shows the I-V relationships of mock ( 
Localization of Thr485 in NBCe1-A With [ 14 C]NEM Probing
Our previous study using the cysteine-reactive chemical biotin maleimide (BM) showed that Thr485 is not exposed to the intraor extracellular aqueous surfaces of NBCe1-A, indicating it resides in TM3 within the plasma membrane (46) . Given the minimal structural and chemical difference between threonine and serine and yet the profound effect of the T485S mutation on the electrogenicity of the transporter, we hypothesized the Thr485 might reside in a functionally critical region such as the ion D: scheme depicting the mechanism of 2-aminoethyl methanethiosulfonate (MTSEA; green dot) labeling. MTSEA is uncharged at pH 7.4 and is therefore plasma membrane permeable. MTSEA accesses an ion interaction site from either the extra-or intracellular surface blocking the function of transporter. E: summary data showing the effect of preincubation with MTSEA (1 mM; 1 min) on T485C base flux in the absence of substrate ions. Error bars represent means Ϯ SE (n ϭ 6). *P Ͻ 0.05. The results were compared with T485C flux without MTSEA whose function was set to 100%. F: representative experimental traces color coded according to the protocols in E.
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PATHOGENIC MECHANISM FOR NBCe1-A-T485S-MEDIATED pRTA permeation pathway or an ion interaction site. To determine whether Thr485 resides in the aqueous-filled ion permeation pathway or an ion interaction site, we tested cysteine-substituted Thr485 for labeling with [ 14 C]NEM, a small thiol-reactive reagent (size of ϳ6 Å in diameter) known be able to enter the substrate permeation pathways of membrane transporters and channels (13) . Like BM, NEM only labels a cysteine residue when its ϪSH group is exposed to an aqueous environment (13) . We performed [ 14 C]NEM labeling on T485C and the other pRTA missense mutations. Of the eight cysteine-substituted pRTA missense mutations, two (R510C and R881C) were not processed to the plasma membrane (46) , and therefore we tested the remaining six plasma membrane processed substitutions for [ 14 C]NEM labeling. The cysteine substitutions were constructed in a modified NBCe1-A backbone lacking five endogenous free reactive cysteines that is fully functional and not labeled with BM (44) . Figure 3 , A and B, shows that after 30 min of incubation with 0.5 mM [ 14 C]NEM, only R298C and T485C were labeled. R298 is located in the NBCe1-A cytoplasmic domain, and the loss of the positive charge at this location was previously predicted to disrupt the local structure of the transporter causing its aqueous exposure (4). The labeling of T485C indicates that Thr485 resides in an aqueous exposed protein interior that is potentially involved in forming part of the NBCe1-A ion permeation pathway or an ion interaction site. The lack of labeling of S427C, G486C, L522C, and A799C indicates that these residues are not exposed to aqueous and therefore are unlikely to be directly involved in ion permeation.
Substrate Ion-Dependent Access of Thr485 to MTSET
To further determine whether Thr485 resides in a functionally important region of NBCe1-A, we tested the functional inhibition of T485C by MTS reagents by preincubating the transporter with these reagents in the absence and presence of substrate ions. Unlike [
14 C]NEM probing, this assay distinguishes whether a residue is located in the ion permeation pathway, versus a residue residing in an ion interaction site. Specifically, the ion interaction site of membrane transporters undergoes inward and outward facing conformational changes, and this process is dependent on the presence of substrate ions (10) . Therefore, if a residue resides in an ion interaction site, its accessibility to a membrane-impermeable MTS reagent (MTSET) can only occur when the ion interaction site is in an out-facing conformation (2) . In contrast, if a residue lines the ion permeation pathway, its accessibility to MTSET is unaffected by the presence or absence of substrate ions.
We hypothesized that if Thr485 resides in a structurally confined ion interaction site, MTSET would have access to the site when the transporter is in an outward facing conformation but not when the transporter is in an inward facing conformation (Fig. 4A) . To test this, we preincubated cells expressing NBCe1-A-T485C with MTSET (4 mM; 5 min) in the presence or absence of Na ϩ , and/or HCO 3 Ϫ -buffered solutions before the base transport pH i measurements. Figure 4 , B and C, shows that base flux was inhibited only when the cells were preincubated with MTSET in a HCO 3 Ϫ -buffered solution containing Na ϩ . This result demonstrates that both Na ϩ and HCO 3 Ϫ -buffer are required to trigger NBCe1-A outward conformational changes making Thr485 accessible to external MTSET. Furthermore, this finding suggests that NBCe1-A adopts an inward facing conformation in the absence of ion substrates. To confirm that Thr485 is accessible to the intracellular medium in the inward facing conformation, we tested the functional sensitivity of T485C to the inhibition of a membrane-permeable MTS reagent, MTSEA, which is able to gain access to the ion inter- Ϫ (labeled as 5C Ϫ ), NBCe1-A-C1035 (labeled as C1035), T485C, G486C, and T485C/ G486R. Immunostaining with Ab-162 against extracellular loop 3 indicated that all the constructs were well expressed. B: summary of NEM labeling. The level of [
14 C]NEM incorporation in each sample was quantified as described in Fig. 3 . In each experiment, the level of [ 14 C]NEM incorporation was normalized to C1035, whose labeling was set to 100%. Error bars represent means Ϯ SE (n ϭ 4). C: representative experimental traces of G486 substituted with Ala (red) and Arg (blue) in comparison to wt-NBCe1-A (black). D: summary data showing the effect of various G486 substitutions expressed as a percentage of wt-NBCe1-A base flux. Error bars represent means Ϯ SE (n ϭ 7-10). *P Ͻ 0.05.
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PATHOGENIC MECHANISM FOR NBCe1-A-T485S-MEDIATED pRTA action site regardless of whether the transporter is in outward or inward facing conformations (Fig. 4D) . T485C-transfected cells were preincubated with 1 mM MTSEA in the absence of substrate ions followed by base flux measurements. With 1 min of incubation, MTSEA inhibited T485C base flux by ϳ60% (Fig. 4, E and F) . These findings complement the previous [ 14 C]NEM labeling results indicating that Thr485 resides in an NBCe1-A ion interaction site.
Effect of Missense Mutation G486R on [ 14 C]NEM Access to Thr485
The interpretation of our finding that Thr485 resides in a structurally confined ion interaction site is further corroborated by "an experiment of nature" wherein an adjacent residue, Gly486, when mutated to arginine (G486R) causes pRTA (37) . Unlike Thr485, Gly486 is inaccessible to aqueous indicated by the lack of [ 14 C]NEM labeling ( Fig. 3B and Fig. 5, A and B) , suggesting that it is not lining the NBCe1-A ion permeation pathway. We hypothesized that the G486R mutation impairs NBCe1-A transport by altering the position of adjacent Thr485 in the ion interaction site. To address this, we created a T485C/G486R construct and analyzed its accessibility to [ 14 C]NEM labeling. Figure 5 , A and B, shows that Arg substitution of Gly486 significantly decreased [ 14 C]NEM labeling of T485C and that the T485C/ G486R construct had minimal base transport activity (ϳ 10% of wt-NBCe1-A) (Fig. 5, C and D) , indicating that the combined effect of the two mutations exceeds the effect of T485S alone. We predicted that the bulky side chain of Arg at Gly486 is likely responsible for the altered position of Thr485 in the ion interaction site (Gly being the smallest amino acid), and therefore we individually substituted Gly486 in wt-NBCe1-A with various sized amino acids (Ala, Cys, Gln, Trp) and measured their base transport function. Figure 5 , C and D, shows that substitution of Gly486 with amino acids having large side chains decreased the transporter function to a similar level (ϳ30% of wtNBCe1-A); however, substitution with Ala, an amino acid with a small side chain, significantly rescued the transporter function (ϳ80% of wt-NBCe1-A). We also examined the functional effect of substitution of Gly486 with charged residues (Arg, Asp, Glu), which showed similar functional impairment. These results suggest that the bulky side chain of Arg at Gly486 has a profound effect on the location of Thr485 in the ion interaction site, supporting the conclusion that Thr485 is critically positioned in an NBCe1-A ion interaction site.
Mechanism of NBCe1-A-T485S Conversion Into an Electroneutral Transporter
Charge transport stoichiometry of NBCe1-A. Our experiments have shown that the T485S mutant transporter is electroneutral and that Thr485 resides in an NBCe1-A ion interaction site. We hypothesized that the T485S mutation may have affected the substrate ion interaction with the NBCe1-A ion interaction site thereby altering its electrogenic property. To address this, we first determined the charge transport stoichiometry of wt-NBCe1-A expressed in mammalian HEK 293 cells by measuring the reversal potential (E rev ) using whole cell voltage clamp. We calculated the charge transport Figure 6 shows that at both Na ϩ concentration gradients, the charge transport stoichiometry was 1:2; specifically, one positive and two negative charges were transported. The results complement previous studies of rat NBCe1-A expressed in Xenopus oocytes where the charge transport stoichiometry was also shown to be 1:2 (14, 27, 33) .
NBCe1-A anion transport. The fact that NBCe1-A has a 1:2 charge transport stoichiometry is compatible with both 1 Na C398 PATHOGENIC MECHANISM FOR NBCe1-A-T485S-MEDIATED pRTA two possibilities, given the technical inability to directly monitor HCO 3 Ϫ and CO 3 2Ϫ transport, we screened for a surrogate anion (ChemBio Office 2010, CambridgeSoft) that could be potentially transported by NBCe1-A. As shown in Fig. 7 and Table 1, NO 3 Ϫ closely mimics CO 3 2Ϫ in its molecular radius, sterical structure, and surface electrostatic characteristics.
To test whether NO 3 Ϫ is transported by NBCe1-A, we used a pH i -based assay taking advantage of the fact that HEK 293 cells have an endogenous ␣-CHC-inhibitable H ϩ -NO 3 Ϫ cotransport process (Fig. 8, A, B , and E) (6). Specifically, NBCe1-A mediated NO 3 Ϫ transport would drive subsequent H ϩ flux via the endogenous H ϩ -NO 3 Ϫ process resulting in predictable pH i changes (Fig. 8C) . Importantly, NBCe1-A mediated NO 3 Ϫ transport cannot alter pH i per se because of the low pK (ϳ1.6) of the NO 3 Ϫ -HNO 3 equilibrium. Figure 8C shows that, in NBCe1-A-expressing cells bathed in a NO 3 Ϫ -containing (25 mM) HEPES-buffered solution, the addition of Na ϩ triggered a DIDS-sensitive pH i increase, but not in mock-transfected cells. This pH i increase could be inhibited by blocking the endogenous H ϩ -NO 3 Ϫ cotransport process with ␣-CHC (Fig. 8C) . Control experiments in a HCO 3 Ϫ -buffered solution showed that ␣-CHC had no inhibitory effect on NBCe1-A base transport per se (Fig. 8D) .
We then performed whole cell patch-clamp measurements to determine the electrogenicity of NBCe1-A-mediated NO 3 Ϫ transport. Figure 9A shows that in a NO 3 Ϫ -containing HEPES-buffered solution, no NBCe1-A current was detected. In contrast, a robust current was detected in HCO 3 Ϫ -buffered solution. The patch-clamp findings together with the pH i results suggest that NBCe1-A mediates electroneutral Na ϩ -driven NO 3 Ϫ transport as predicted with a 1 Na ϩ :1 NO 3 Ϫ charge transport stoichiometry. Based on these results, we conclude that in HCO 3 Ϫ -buffered solution, NBCe1-A mediates electrogenic Na ϩ -CO 3 2Ϫ cotransport functioning with a 1:2 charge transport stoichiometry. . The latter two modes of transport would be predicted to transport NO 3 Ϫ electrogenically (1ϩ charge). As shown in Fig. 9B , electrophysiologic measurements demonstrated that in the presence of NO 3 Ϫ , T485S failed to generate the positive current expected in mode 2 or mode 3 transport. Furthermore, pH i measurements (Fig. 9, C  and D) showed that T485S completely eliminated the ability of NBCe1-A to transport NO 3 Ϫ , implying that it is unable to transport CO 3
2Ϫ
, arguing against transport modes 2 and 3. Therefore, the T485S mutant has the following transport properties: 1) ϳ50% of 2 If wild-type NBCe1-A functions with a 1:2 charge transport stoichiometry by mediating 1 Na ϩ ϩ 2 HCO 3 Ϫ transport, substitution of NO 3 Ϫ for HCO 3
Ϫ
would not be predicted to alter the electrogenicity of the transporter, i.e., NO 3 Ϫ transport would be mediated with a 1:2 charge transport stoichiometry (Ϫ1 net charge). However, our data indicate that wild-type NBCe1-A transports NO 3 Ϫ electroneutrally arguing against this model. In addition, the finding that the mutant transporter likely mediates electroneutral Na ϩ -HCO 3 Ϫ cotransport but not Na ϩ -NO 3 Ϫ cotransport also argues against NO 3 Ϫ substitution for HCO 3 Ϫ . Fig. 7 . Structural homology screen was performed using ChemBio Office 2010 program. CO 3 2Ϫ was set as the target molecule for the overlay algorithm. The various molecules examined are displayed in a ball and stick mode with wire surface mesh, and overlays are shown using a ball and stick mode with dot surface. When depicted as single molecules, CO 3 2Ϫ and NO 3 Ϫ share the greatest structural similarity, as is further highlighted in Table 1 . Ϫ transport (1 Na ϩ and 1 HCO 3 Ϫ per transport cycle) with ϳ50% of the wild-type base flux.
DISCUSSION
pRTA can be an acquired or hereditary disorder (9) . Of the known hereditary diseases that impair proximal tubule HCO 3 Ϫ absorption, mutations in NBCe1 cause severe pRTA associated with ocular and cerebral manifestations. Here we explored in detail the mechanism of how a seemingly unlikely amino acid substitution in NBCe1-A, T485S, causes pRTA. Our findings demonstrated that the T485S mutation converts the transporter from an electrogenic Na ϩ -CO 3 2Ϫ cotransporter into an electroneutral Na ϩ -HCO 3 Ϫ cotransporter. The loss of electrogenicity of NBCe1-A represents a new pathogenic mechanism causing pRTA, and by inference, a new mechanism as to how missense mutations in electrogenic membrane transporters can potentially cause human disease. Because of the structural and chemical similarity between serine and threonine, it would not be predicted that this substitution would cause human disease. Thr485 resides in NBCe1-A-TM3 where it is inaccessible to the bulky chemical, biotin maleimide (46) . Given the chemical and structural similarities between Thr and Ser and its location in the protein interior, we predicted that Thr485 might be positioned in a functionally critical site in NBCe1-A where a subtle local structural alteration could significantly affect the function of the cotransporter. Indeed, when probed with [
14 C]NEM, T485C was shown to be accessible to the aqueous, and importantly, functional characterization with membrane-impermeable (MTSET) and membrane-permeable (MTSEA) MTS reagents indicated that Thr485 is in a location that undergoes substrate-dependent intra-and extracellular facing conformational changes. These findings are compatible with a transporter model where Thr485 
Pro-S Bond lengths and bond angles of the atoms were measured by the ChemBio Office 2010 program.
C400
PATHOGENIC MECHANISM FOR NBCe1-A-T485S-MEDIATED pRTA resides in an NBCe1-A ion interaction site. This conclusion is further supported by the observation that a pRTA-causing missense mutation, G486R, which is adjacent to T485, could alter the position of Thr485 in NBCe1-A, likely leading to a significant functional impairment of the transporter. NBCe1-A transports ions electrogenically across the plasma membrane, and its electrogenic property is critical for HCO 3 Ϫ absorption in the proximal tubule. We hypothesized that if a mutation occurred in an ion interaction site, it would significantly affect both NBCe1-A base transport and its electrogenic property. We and others have determined that, in the presence of T485S, the base transport function of mutant NBCe1-A decreased ϳ50% (15, 38, 46) . Here, we report for the first time that the base transport mediated by NBCe1-A-T485S is electroneutral. The finding that Thr substitution with Ser at this position not only impairs base transport but also renders the transporter electroneutral is compatible with our data indicating that Thr485 resides in an NBCe1-A ion interaction site.
To address the molecular mechanism why T485S mutation caused a loss of NBCe1-A electrogenicity, we first determined the wt-NBCe1-A charge transport stoichiometry by measuring the reversal potential (E rev ) of the transporter at known ion gradients. Based on the E rev measurements at two different Na ϩ gradients, we demonstrated that, in HEK 293 cells, the NBCe1-A charge transport stoichiometry is 1:2 (1 positive charge: 2 negative charges). This is in agreement with previous measurements of the stoichiometry of NBCe1-A expressed in Xenopus oocytes (14, 27, 33 , an intracellular acidification (Ϫ0.11 Ϯ 0.02 pH/min, n ϭ 7) due to endogenous H ϩ -NO 3 Ϫ influx, was observed that was reversible. B: 2 mM ␣-CHC significantly decreased the endogenous H ϩ -NO 3 Ϫ cotransport process (Ϫ0.03 Ϯ 0.007 pH/min, n ϭ 3; P Ͻ 0.05) (5) . C: to monitor NBCe1-A-mediated Na ϩ -driven NO 3 Ϫ flux, cells were initially acidified using an NH4Cl prepulse in the absence of Na ϩ , in HEPES-buffer containing 25 mM NO 3 Ϫ . All solutions also contained 15 M EIPA to block endogenous Na ϩ /H ϩ exchange activity. In NBCe1-A-transfected cells, the addition of Na ϩ induced an intracellular alkalinization due to NBCe1-A-mediated Na ϩ -driven NO 3 Ϫ influx with subsequent stimulation of H ϩ -NO 3 Ϫ cotransport (black; mean flux of 4.05 Ϯ 0.30 mM/min, n ϭ 8). Blocking NBCe1-A with DIDS (blue; 1 mM) prevented the transport flux (0.23 Ϯ 0.12 mM/min, n ϭ 4, P Ͻ 0.05). The transport flux was ␣-CHC sensitive (red; 0.65 Ϯ 0.10 mM/min, n ϭ 3, P Ͻ 0.05) since in the absence of endogenous H ϩ -NO 3 Ϫ cotransport stimulation, the assay will not detect NBCe1-A-mediated Na ϩ -driven NO 3 Ϫ influx. In mock-transfected cells (green), Na ϩ -driven intracellular alkalinization was not detectable. D: control experiments showing that ␣-CHC does not inhibit wt-NBCe1-A base transport flux in HCO 3 Ϫ -buffered solution [16.8 Ϯ 3 .59 mM/min (n ϭ 7) vs. control 16.7 Ϯ 1.20 mM/min (n ϭ 8); P ϭ not significant]. E: cell model depicting the mechanism of the NBCe1-A-mediated increase in pHi in C where endogenous H ϩ -NO 3 Ϫ cotransport efflux is stimulated following NBCe1-A-mediated Na ϩ -driven NO 3 Ϫ influx.
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PATHOGENIC MECHANISM FOR NBCe1-A-T485S-MEDIATED pRTA flux could be monitored by measuring pH i changes. A similar approach had previously been successfully used to monitor Na ϩ lactate cotransport in the proximal tubule (36) . Our data showed that NBCe1-A mediates DIDS-inhibitable Na ϩ -dependent NO 3 Ϫ transport. We predicted that if NBCe1-A transports 1 Na ϩ and 1 CO 3 2Ϫ , NO 3 Ϫ , which has one less negative charge than CO 3 2Ϫ , would be transported electroneutrally. Indeed, whole cell path-clamp measurements in the presence of Na ϩ and NO 3 Ϫ showed that no measurable currents could be detected, whereas in the presence of Na ϩ and CO 3 2Ϫ , a robust current was observed. Our findings provide strong evidence that the anion transported by NBCe1-A is CO 3 2Ϫ rather than HCO 3 Ϫ . Preliminary results in Xenopus oocytes using surface pH measurements also suggested that CO 3 2Ϫ may be the transported anion (20) .
Electroneutral transport by the T485S mutant in HCO 3 Ϫ -buffered solution would be predicted with either a 2 Na ϩ ϩ 1 CO 3 2Ϫ or 1 Na ϩ ϩ 1 H ϩ ϩ 1 CO 3 2Ϫ transport mode. However, our electrophysiologic and pH i -based NO 3 Ϫ transport studies are not compatible with these modes of transport. The simplest and most plausible explanation that accounts for our data is that the mutant transporter mediates electroneutral Na ϩ -HCO 3 Ϫ cotransport rather than electrogenic Na ϩ -CO 3 2Ϫ cotransport. The molecule simulation analysis indicated that HCO 3 Ϫ differs from CO 3 2Ϫ in the molecular shape and surface electrostatic properties. We propose that HCO 3 Ϫ fits better in the modified anion binding pocket of the mutant transporter. Moreover, the loss of the ϪCH3 group caused by Ser substitution at Thr485 may change the spatial configuration of the anion binding pocket so that it preferentially interacts with HCO 3 Ϫ , leading to electroneutral base transport.
The charge transport stoichiometry of heterologously expressed NBCe1-A has been investigated by several groups and has been determined to be either 1:2 or 1:3 (31). Cell-specific factors (11), phosphorylation status of the transporter (12) , and changes in Ca 2ϩ (27) have been reported to play a role in modifying the charge transport stoichiometry. Whether the differences in charge transport stoichiometry are also in part due to factors including assay methods, or less than an optimal signal/noise ratio of the methodology used remains unresolved.
Previous studies in the rat proximal tubule have reported a transporter stoichiometry in vivo of 1:3 (43) . In the isolated perfused rabbit proximal tubule in vitro, the transporter stoi- Fig. 9 . Effect of T485S/C on wt-NBCe1-A-mediated NO 3 Ϫ transport. A: wt-NBCe1-A-mediated current was detected in the presence of HCO 3 Ϫ -buffered solution, but not in HEPES or HEPES-buffer containing 25 mM NO 3 Ϫ (n ϭ 3). B: lack of T485S-mediated current in HEPES buffer or HEPES buffer containing 25 mM NO 3 Ϫ (n ϭ 4). C: representative experiments showing that addition of Na ϩ in the presence of 25 mM NO 3 Ϫ in HEPES buffer induced a pHi increase in cells expressing wt-NBCe1-A (black). In cells expressing T485S (red) or T485C (blue), the increase in pHi was not detectable. D: summary data of results of the experiments in C (n ϭ 7). *P Ͻ 0.05. (28) . In Necturus proximal tubules in vivo, the transporter stoichiometry was 1:3 and changed to 1:2 during acute respiratory acidosis (30) . Based on these studies, it has been assumed without definitive evidence that in the human proximal tubule, NBCe1-A has a 1:3 charge transport stoichiometry. Indeed, an important question resulting from our study is whether the 1:2 charge transport stoichiometry of human NBCe1-A expressed in HEK 293 represents the actual stoichiometry in vivo. Whether the ambient in vivo gradients of the transported ions and the basolateral membrane potential in human proximal tubules are such that a 1:2 charge transport stoichiometry is sufficient to drive proximal tubule basolateral Na ϩ -CO 3 2Ϫ efflux is currently unknown. To address this question definitively in the intact human proximal tubule will be difficult. Although several purported human proximal tubule cell lines are available, we currently lack an acceptable human (or simian) proximal tubule cultured cell system that recapitulates the acid-base transport properties of the proximal tubule in a polarized fashion (i.e., expresses apical NHE3 and basolateral NBCe1-A). Using available data from the rat proximal tubule (Table 2) , wild-type NBCe1-A functioning as a Na ϩ -CO 3 2Ϫ cotransporter (1:2 charge transport stoichiometry) would mediate a reabsorptive flux, although the transporter is predicted to be near equilibrium. Accordingly, the direction of flux across NBCe1-A in vivo would vary with small changes in the electrochemical chemical potential of its transported ions. For a 1:3 charge transport stoichiometry (Na ϩ -CO 3 2Ϫ -HCO 3 Ϫ cotransport), the direction of transport is less dependent on the cellular-basolateral chemical gradients of the transported species and the basolateral membrane potential. Given the aforementioned considerations, it is instructional to model what might be occurring with wt-NBCe1-A functioning as an electrogenic Na ϩ -CO 3 2Ϫ cotransporter in the context of T485S pRTA mutation in vivo. As shown in Fig. 10 , electroneutral NBCe1-A-T485S being insensitive to the basolateral membrane potential (dependent in part on K ϩ channel activity such as TASK2) (40) Ϫ transport is mediated by the coupling of apical Na ϩ /H ϩ exchange (NHE3) and basolateral NBCe1-A functioning as an electrogenic Na ϩ -CO 3 2Ϫ cotransporter with a 1:2 charge transport stoichiometry. C: NBCe1-A-T485S switches the substrate anion preference from CO 3 2Ϫ to HCO 3 Ϫ , thereby altering the electrogenicity of NBCe1-A. NBCe1-A-T485S is predicted to mediate electroneutral Na ϩ -HCO 3 Ϫ influx into proximal tubular cells. The T485S mutation is indicated as a brown diamond in an anion interaction site. Model II. D and E: depiction of wt-NBCe1-A-mediated electrogenic Na ϩ -CO 3 2Ϫ -HCO 3 Ϫ cotransport with a 1:3 charge transport stoichiometry. F: NBCe1-A-T485S eliminates the CO 3 2Ϫ interaction site converting NBCe1-A into an electroneutral Na ϩ -HCO 3 Ϫ cotransporter.
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PATHOGENIC MECHANISM FOR NBCe1-A-T485S-MEDIATED pRTA chiometry in vivo, and assuming ion transport is mediated by 1 Na ϩ ϩ 1 CO 3 2Ϫ ϩ 1 HCO 3 Ϫ , loss of CO 3 2Ϫ interaction due to the T485S mutation would also be predicted to result in electroneutral Na ϩ -HCO 3 Ϫ cotransport with concomitant reversal of basolateral membrane base flux and subsequent impaired transepithelial HCO 3 Ϫ absorption.
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No conflicts of interest, financial or otherwise, are declared by the author(s). Ϫ -independent conductance with a mutant Na ϩ -HCO 3 Ϫ cotransporter (SLC4A4) 3 In a preliminary mathematical model of the rat proximal tubule epithelial transport, we estimated the impact of altered NBCe1-A stoichiometry on cell volume, intracellular ion composition, and transport. When a mutant basolateral NBCe1-A transporter with a 1:1 charge transport stoichiometry is introduced into the cell model, in a time-dependent simulation, there is basolateral Na ϩ -HCO 3 Ϫ cellular influx, producing cell swelling and alkalinization. This blunts Na ϩ entry (and proton secretion) via luminal NHE3, and with continued activity of the Na ϩ -K ϩ -ATPase, there is little change in cytosolic Na ϩ concentration. However, the cell continues to swell infinitely, without a steady-state solution to this model simulation, suggesting that other compensatory mechanisms would need to be operative in vivo (i.e., opening of a basolateral anion conductance).
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